securities fraud

Class action lawsuit filed against $UHG alleging materially false statements and nondisclosure of controlling shareholder's intentions to force company sale and devalue assets.

Class action lawsuit filed against Nektar Therapeutics alleging false statements about REZOLVE-AA trial enrollment protocols. Investors harmed between February-December 2025 can join case.

Super Micro Computer faces class action lawsuit alleging undisclosed Chinese sales violating U.S. export controls and material compliance weaknesses from February 2024 through March 2026.

Class action lawsuit filed against Driven Brands Holdings alleging materially false financial statements, weak internal controls, and accounting discrepancies spanning fiscal 2023-2024.

Apollo Global Management faces class action lawsuit alleging executives falsely denied business dealings with Jeffrey Epstein. Investors from May 2021–February 2026 eligible to join.

Class action lawsuit filed against LKQ Corporation alleging executives made false statements about FinishMaster acquisition integration risks and promised strategic benefits.

Class action filed against $PINS alleging false statements on advertising revenue, tariff impacts, and nondisclosed restructuring from Feb 2025-2026.

Class action filed against Babcock & Wilcox alleging undisclosed conflicts in Applied Digital contract and overstated financial prospects. Securities holders from November 2025-March 2026 may be eligible.

Class action lawsuit filed against Lufax Holding Ltd alleging securities fraud and inadequate internal controls. Lead plaintiff deadline set for May 20, 2026.

Portnoy Law Firm files class action against Boston Scientific after 17% stock plunge following Q4 earnings miss and allegations of misled growth projections.

Portnoy Law Firm files class action against Camping World Holdings for allegedly misstating inventory capabilities and consumer demand between April 2025 and February 2026. Investors have until May 11, 2026 to file lead plaintiff motions.

Portnoy Law Firm files class action against Aquestive Therapeutics for allegedly misleading investors about Anaphylm drug approval prospects, citing undisclosed FDA deficiencies.

Portnoy Law Firm files class action against ChowChow Cloud after stock plummets 84.3% in single day following alleged social media manipulation scheme.

Rosen Law Firm filed class action lawsuit against Regencell Bioscience ($RGC) alleging false statements and regulatory risk non-disclosure. Lead plaintiff deadline: June 23, 2026.

Class action filed against $REGENCELL for alleged false statements regarding market manipulation vulnerability and regulatory exposure between October 2024-2025.

Rosen Law Firm files class action against SES AI for alleged materially false statements regarding revenue and business prospects from Jan. 2025-Mar. 2026.

Schall Law Firm recruits SES AI investors for securities fraud class action over alleged false statements regarding partnerships and Molecular Universe platform misrepresentations.

Rosen Law Firm sues Globant ($GLOB) alleging misrepresentation of Latin American strategy success amid declining demand, client losses, and wage freezes.

monday.com faces securities fraud lawsuit after retracting $1.8B revenue target. Stock crashed from $189.59 to $77.63 on alleged management misstatements.

Class action lawsuit alleges $ATRA misrepresented manufacturing issues and clinical trial deficiencies for tabelecleucel, obscuring FDA approval challenges between May 2024 and January 2026.